TAFASITAMAB-CXIX for Marginal zone lymphoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 13 adverse event reports in the FDA FAERS database where TAFASITAMAB-CXIX was used for Marginal zone lymphoma.
Most Reported Side Effects for TAFASITAMAB-CXIX
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Disease progression | 218 | 29.6% | 41 | 8 |
| Lymphoma | 158 | 21.5% | 3 | 7 |
| Off label use | 126 | 17.1% | 7 | 20 |
| Death | 53 | 7.2% | 53 | 3 |
| Drug ineffective | 39 | 5.3% | 19 | 5 |
| Blood lactate dehydrogenase increased | 34 | 4.6% | 14 | 0 |
| Diffuse large b-cell lymphoma | 32 | 4.4% | 13 | 4 |
| Malignant neoplasm progression | 30 | 4.1% | 5 | 3 |
| Neutropenia | 30 | 4.1% | 5 | 7 |
| Polyneuropathy | 29 | 3.9% | 0 | 8 |
| Covid-19 | 28 | 3.8% | 9 | 17 |
| Cytopenia | 25 | 3.4% | 0 | 1 |
| Ill-defined disorder | 21 | 2.9% | 0 | 1 |
| Product use issue | 21 | 2.9% | 2 | 1 |
| Neoplasm progression | 20 | 2.7% | 7 | 0 |
Other Indications for TAFASITAMAB-CXIX
Diffuse large b-cell lymphoma (429)
Product used for unknown indication (115)
Follicular lymphoma (58)
Diffuse large b-cell lymphoma refractory (31)
Lymphoma transformation (23)
Lymphoma (13)
Diffuse large b-cell lymphoma recurrent (8)
Non-hodgkin's lymphoma (7)
B-cell lymphoma (5)
Marginal zone lymphoma refractory (5)
Other Drugs Used for Marginal zone lymphoma
RITUXIMAB (706)
IBRUTINIB (519)
LENALIDOMIDE (321)
OBINUTUZUMAB (188)
ETOPOSIDE (176)
BENDAMUSTINE (174)
CYCLOPHOSPHAMIDE (173)
IFOSFAMIDE (151)
METHOTREXATE (138)
DOXYCYCLINE (135)